Eu Ivdd Eu Ivd Annex 2 List B On The Market 🇫🇮 Finland

Neonatal Toxoplasma gondii IgM FEIA

Labsystems Diagnostics Oy · 🇫🇮 Finland
Devices (same UDI-DI)
1
Certificates
1
Countries
0
Notified Bodies
1

Basic Information

Primary DI
06438172116016
Basic UDI-DI Code
B-06438172116016
Reference
6199802
Device Types
None provided
Regulation
Eu Ivdd
Classification
Eu Ivd Annex 2 List B
Status
On The Market

Additional Description

This Neonatal Toxoplasma gondii IgM FEIA kit is intended for the determination of IgM-class antibodies to Toxoplasma gondii in blood samples dried on filter paper. The test is intended as a primary method for screening of newborns for congenital toxoplasmosis (CT). Because IgM-class antibodies due to their high molecular weight do not cross placenta, determination of specific antibodies in newborn samples taken shortly after birth indicates exposure of the fetus intra utero to Toxoplasma gondii. Cases showing elevated levels of specific antibodies should be further investigated.

CND Nomenclature Codes

Code Description
W0105050103 TOXOPLASMA ANTIBODY IGM

Certificates

Type Number
IVDD Annex IV (excluding sections 4, 6) C-02-1172-794-22

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd Annex 2 List B) and regulation (EU IVDD).

View all